Results 121 to 130 of about 151,397 (297)

Qualitative assessment of online information about age-related macular degeneration available in Portuguese

open access: yesEinstein (São Paulo)
Objective: To evaluate the quality of online information on age-related macular degeneration available in Portuguese. Methods: The search term “age-related macular degeneration” was used to browse the web using four different search engines.
Jorge Agi   +2 more
doaj   +1 more source

Characterizing and assessing vision‐related quality of life among patients discontinued treatment for neovascular age‐related macular degeneration

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose This study characterized and assessed vision‐related quality of life (VRQoL) in patients with neovascular age‐related macular degeneration (nAMD) who discontinued treatment with intravitreal anti‐vascular endothelial growth factor (anti‐VEGF), comparing them to those undergoing treatment.
Noreddin Shekho   +4 more
wiley   +1 more source

Seasonal variation in the incidence of central serous chorioretinopathy: A systematic review and meta‐analysis

open access: yesActa Ophthalmologica, EarlyView.
Abstract Central serous chorioretinopathy (CSC) is a chorioretinal disease characterised by serous subretinal fluid (SRF) in the macula, resulting in sudden central vision loss. It predominantly affects working‐age adults, particularly men aged 30 to 60 years.
I. Made Ferdiko Hutamadella   +10 more
wiley   +1 more source

Direct and indirect costs associated with declining distance visual acuity: A nationwide longitudinal cost‐of‐illness study with 11‐year follow‐up

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To examine the direct and indirect costs associated with declining distance visual acuity (VA). Methods A longitudinal approach was applied to a large, nationally representative sample with extensive data, including VA measured at two time points.
Joonas Taipale   +5 more
wiley   +1 more source

Potential role of lampalizumab for treatment of geographic atrophy

open access: yesClinical Ophthalmology, 2015
William Rhoades, Drew Dickson, Diana V Do Truhlsen Eye Institute, Department of Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, NE, USA Abstract: The purpose of this article is to review the pathways underlying age ...
Rhoades W, Dickson D, Do DV
doaj  

Cerebro-Macular Degeneration [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1931
E D, Macnamara, W E, Dickson, T R, Hill
openaire   +2 more sources

Infection control in the brain and the eye

open access: yesActa Ophthalmologica, EarlyView.
Abstract The Central Nervous System (CNS), comprising the brain and the eye, is considered to have a ‘privileged’ mechanism for dealing with immunological challenge (immune privilege, IP). CNS IP has been revealed through experiments using foreign protein antigens and cell and tissue alloantigens (grafts), but evidence for a role for IP in modulating ...
John V. Forrester   +2 more
wiley   +1 more source

Hybrid Integent Staging of Age-Related Macular Degeneration for Decision-Making on Patient Management Tactics

open access: yesApplied Sciences
Treatment efficacy for age-related macular degeneration relies on early diagnosis and precise determination of the disease stage. This involves analyzing biomarkers in retinal images, which can be challenging when handling a large flow of patients and ...
Ekaterina A. Lopukhova   +6 more
doaj   +1 more source

Neovascular age-related macular degeneration without drusen. [PDF]

open access: yesActa Ophthalmol
Abstract Purpose To describe the clinical characteristics and 1‐year follow‐up of patients with neovascular AMD (nAMD) without drusen in either eye. Methods This is a multicentre retrospective cohort study in three tertiary referral centres in The Netherlands. We included patients of 55 years or older with nAMD in one or both eyes, without the presence
Sirks MJ   +9 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy